Globus Medical (GMED) ROE: History & Chart

Globus Medical, Inc.(GMED)

Medical - Devices · Audubon, PA

$82.54-0.56 (-0.67%)

Delayed quote: Aug 27, 2026, 4:00 PM EDT

About Globus Medical, Inc.

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Audubon, PA

6,000 employees

www.globusmedical.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Keith W. Pfeil

View full financials

GMED Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

11.23%

RETURN ON EQUITY (ROE) AVG TTM

10.67%

RETURN ON EQUITY (ROE) AVG 3Y

6.34%

RETURN ON EQUITY (ROE) AVG 5Y

7.61%

RETURN ON EQUITY (ROE) AVG 10Y

9.73%

RETURN ON EQUITY (ROE) AVG 15Y

11.62%

RETURN ON EQUITY (ROE) AVG 20Y

N/A

CURRENT VS TTM AVG

+5.29%

CURRENT VS 3Y AVG

+77.07%

CURRENT VS 5Y AVG

+47.57%

CURRENT VS 10Y AVG

+15.41%

CURRENT VS 15Y AVG

-3.34%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

11.44%

median of 88 covered companies

CURRENT VS SECTOR MEDIAN

-1.85%

vs the sector median at left

NAME	MARKET CAP	RETURN ON EQUITY (ROE)	TTM	3Y	5Y
Globus Medical, Inc. (GMED)	$11.13B	11.23%	10.67%	6.34%	7.61%
Bio-Techne Corporation (TECH)vs ›	$11.35B	8.63%	6.23%	8.78%	10.01%
Align Technology, Inc. (ALGN)vs ›	$11.38B	9.77%	10.54%	10.84%	19.93%
DaVita Inc. (DVA)vs ›	$11.48B	-114.70%	329.18%	200.63%	164.66%
Bio-Rad Laboratories, Inc. (BIO)vs ›	$10.50B	3.10%	-8.94%	-15.72%	1.14%
Universal Health Services, Inc. (UHS)vs ›	$10.45B	20.31%	18.80%	15.17%	15.31%
Encompass Health Corporation (EHC)vs ›	$11.86B	23.91%	22.63%	21.83%	21.13%
Molina Healthcare, Inc. (MOH)vs ›	$10.37B	-0.17%	18.91%	22.60%	24.60%
Henry Schein, Inc. (HSIC)vs ›	$10.28B	12.77%	11.88%	12.69%	13.50%
The Ensign Group, Inc. (ENSG)vs ›	$10.11B	15.51%	15.81%	15.92%	17.27%

NAME

MARKET CAP

RETURN ON EQUITY (ROE)

TTM

Globus Medical, Inc. (GMED)

$11.13B

11.23%

10.67%

6.34%

7.61%

Bio-Techne Corporation (TECH)vs ›

$11.35B

8.63%

6.23%

8.78%

10.01%

Align Technology, Inc. (ALGN)vs ›

$11.38B

9.77%

10.54%

10.84%

19.93%

DaVita Inc. (DVA)vs ›

$11.48B

-114.70%

329.18%

200.63%

164.66%

Bio-Rad Laboratories, Inc. (BIO)vs ›

$10.50B

3.10%

-8.94%

-15.72%

1.14%

Universal Health Services, Inc. (UHS)vs ›

$10.45B

20.31%

18.80%

15.17%

15.31%

Encompass Health Corporation (EHC)vs ›

$11.86B

23.91%

22.63%

21.83%

21.13%

Molina Healthcare, Inc. (MOH)vs ›

$10.37B

-0.17%

18.91%

22.60%

24.60%

Henry Schein, Inc. (HSIC)vs ›

$10.28B

12.77%

11.88%

12.69%

13.50%

The Ensign Group, Inc. (ENSG)vs ›

$10.11B

15.51%

15.81%

15.92%

17.27%

Return on Equity (ROE) FAQ

What is the return on equity (ROE) for Globus Medical, Inc. (GMED)?

The return on equity (ROE) for GMED stock is 11.23%.

Is Globus Medical, Inc.'s return on equity (ROE) high or low?

The return on equity (ROE) of 11.23% is 48% above its 5-year average of 7.61%, near the high end of its 5-year range (1.02%–12.40%).

What is the TTM average return on equity (ROE) for Globus Medical, Inc. (GMED)?

The TTM average return on equity (ROE) for GMED stock is 10.67%.

What is the 3Y average return on equity (ROE) for Globus Medical, Inc. (GMED)?

The 3Y average return on equity (ROE) for GMED stock is 6.34%.

What is the 5Y average return on equity (ROE) for Globus Medical, Inc. (GMED)?

The 5Y average return on equity (ROE) for GMED stock is 7.61%.

What is the 10Y average return on equity (ROE) for Globus Medical, Inc. (GMED)?

The 10Y average return on equity (ROE) for GMED stock is 9.73%.

What is the 15Y average return on equity (ROE) for Globus Medical, Inc. (GMED)?

The 15Y average return on equity (ROE) for GMED stock is 11.62%.

DATE	RETURN ON EQUITY (ROE)
2026-06-30	11.23%
2026-03-31	12.40%
2025-12-31	11.76%
2025-09-30	9.63%
2025-06-30	8.30%
2025-03-31	4.54%
2024-12-31	2.47%
2024-09-30	2.25%
2024-06-30	1.02%
2024-03-31	1.70%
2023-12-31	3.07%
2023-09-30	3.77%
2023-06-30	10.29%
2023-03-31	10.51%
2022-12-31	10.30%
2022-09-30	8.80%
2022-06-30	9.12%
2022-03-31	7.95%
2021-12-31	8.57%
2021-09-30	10.89%
2021-06-30	11.23%
2021-03-31	7.78%
2020-12-31	6.79%
2020-09-30	6.69%
2020-06-30	6.65%
2020-03-31	10.85%
2019-12-31	11.07%
2019-09-30	10.94%
2019-06-30	11.13%
2019-03-31	12.14%
2018-12-31	13.20%
2018-09-30	12.63%
2018-06-30	12.26%
2018-03-31	11.51%
2017-12-31	11.09%
2017-09-30	11.47%
2017-06-30	11.92%
2017-03-31	12.09%
2016-12-31	12.54%
2016-09-30	14.52%
2016-06-30	15.12%
2016-03-31	15.51%
2015-12-31	15.77%
2015-09-30	15.26%
2015-06-30	15.46%
2015-03-31	15.63%
2014-12-31	15.80%
2014-09-30	15.50%
2014-06-30	15.73%
2014-03-31	13.91%
2013-12-31	14.53%
2013-09-30	15.25%
2013-06-30	15.30%
2013-03-31	18.65%
2012-12-31	19.10%
2012-09-30	18.29%
2012-06-30	20.83%
2012-03-31	21.18%
2011-12-31	21.52%

DATE

RETURN ON EQUITY (ROE)

2026-06-30

11.23%

2026-03-31

12.40%

2025-12-31

11.76%

2025-09-30

9.63%

2025-06-30

8.30%

2025-03-31

4.54%

2024-12-31

2.47%

2024-09-30

2.25%

2024-06-30

1.02%

2024-03-31

1.70%

2023-12-31

3.07%

2023-09-30

3.77%

2023-06-30

10.29%

2023-03-31

10.51%

2022-12-31

10.30%

2022-09-30

8.80%

2022-06-30

9.12%

2022-03-31

7.95%

2021-12-31

8.57%

2021-09-30

10.89%

2021-06-30

11.23%

2021-03-31

7.78%

2020-12-31

6.79%

2020-09-30

6.69%

2020-06-30

6.65%

2020-03-31

10.85%

2019-12-31

11.07%

2019-09-30

10.94%

2019-06-30

11.13%

2019-03-31

12.14%

2018-12-31

13.20%

2018-09-30

12.63%

2018-06-30

12.26%

2018-03-31

11.51%

2017-12-31

11.09%

2017-09-30

11.47%

2017-06-30

11.92%

2017-03-31

12.09%

2016-12-31

12.54%

2016-09-30

14.52%

2016-06-30

15.12%

2016-03-31

15.51%

2015-12-31

15.77%

2015-09-30

15.26%

2015-06-30

15.46%

2015-03-31

15.63%

2014-12-31

15.80%

2014-09-30

15.50%

2014-06-30

15.73%

2014-03-31

13.91%

2013-12-31

14.53%

2013-09-30

15.25%

2013-06-30

15.30%

2013-03-31

18.65%

2012-12-31

19.10%

2012-09-30

18.29%

2012-06-30

20.83%

2012-03-31

21.18%

2011-12-31

21.52%

Return on Equity (ROE): 11.23%

GMED Return on Equity (ROE)

GMED Average Return on Equity (ROE) Chart

GMED Current vs Average Return on Equity (ROE) Chart

GMED Return on Equity (ROE) Metrics

GMED Competitors' Return on Equity (ROE)

Return Analysis

Return on Equity (ROE) Formula & Definition

Return on Equity (ROE) FAQ

GMED Return on Equity (ROE) History

Related Metrics